NCT00549978

Safety and Pharmacokinetics of Probucol and Cilostazol

Phase IV, Safety and Pharmacokinetics of Probucol and Cilostazol When Coadministered in Healthy Subjects

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 32 (actual)
• Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. · Industry
• Sex: Male
• Age: 20 Years – 40 Years
• Healthy volunteers: Accepted

Summary

to investigate the safety and pharmacokinetics, in healthy adult male subjects

Detailed description

Safety and Pharmacokinetics of Probucol and Cilostazol when co-administered in Health Subjects

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Cilostazol	cilostazol, then cilostazol/probucol
DRUG	Probucol	Probucol probucol/ cilostazol

Timeline

• Start date: 2007-10-01
• Primary completion: 2008-05-01
• Completion: 2008-08-01
• First posted: 2007-10-26
• Last updated: 2022-03-04

Locations

1 site across 1 country: South Korea